These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8640823)

  • 1. Adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing human gastric carcinoma cells in vitro.
    Tanaka T; Kanai F; Okabe S; Yoshida Y; Wakimoto H; Hamada H; Shiratori Y; Lan K; Ishitobi M; Omata M
    Cancer Res; 1996 Mar; 56(6):1341-5. PubMed ID: 8640823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-mediated gene therapy of gastric carcinoma using cancer-specific gene expression in vivo.
    Tanaka T; Kanai F; Lan KH; Ohashi M; Shiratori Y; Yoshida Y; Hamada H; Omata M
    Biochem Biophys Res Commun; 1997 Feb; 231(3):775-9. PubMed ID: 9070891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
    Kanai F; Shiratori Y; Yoshida Y; Wakimoto H; Hamada H; Kanegae Y; Saito I; Nakabayashi H; Tamaoki T; Tanaka T; Lan KH; Kato N; Shiina S; Omata M
    Hepatology; 1996 Jun; 23(6):1359-68. PubMed ID: 8675152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing pancreatic cancer.
    Ohashi M; Kanai F; Tanaka T; Lan KH; Shiratori Y; Komatsu Y; Kawabe T; Yoshida H; Hamada H; Omata M
    Jpn J Cancer Res; 1998 Apr; 89(4):457-62. PubMed ID: 9617353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene.
    Osaki T; Tanio Y; Tachibana I; Hosoe S; Kumagai T; Kawase I; Oikawa S; Kishimoto T
    Cancer Res; 1994 Oct; 54(20):5258-61. PubMed ID: 7923150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the Cre recombinase/loxP system further enhances antitumor effects in cell type-specific gene therapy against carcinoembryonic antigen-producing cancer.
    Kijima T; Osaki T; Nishino K; Kumagai T; Funakoshi T; Goto H; Tachibana I; Tanio Y; Kishimoto T
    Cancer Res; 1999 Oct; 59(19):4906-11. PubMed ID: 10519403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro model of suicide gene therapy for alpha-fetoprotein-producing gastric cancer.
    Nakaya H; Ishizu A; Ikeda H; Tahara M; Shindo J; Itoh R; Takahashi T; Asaka M; Ishikura H; Yoshiki T
    Anticancer Res; 2003; 23(5A):3795-800. PubMed ID: 14666679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptionally targeted in vivo gene therapy for carcinoembrionic antigen-producing adenocarcinoma.
    Konishi F; Maeda H; Yamanishi Y; Hiyama K; Ishioka S; Yamakido M
    Hiroshima J Med Sci; 1999 Sep; 48(3):79-89. PubMed ID: 10598410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of sensitivity to ganciclovir in human hepatocellular carcinoma cells by adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase.
    Qian C; Bilbao R; Bruña O; Prieto J
    Hepatology; 1995 Jul; 22(1):118-23. PubMed ID: 7601402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo selective gene expression and therapy mediated by adenoviral vectors for human carcinoembryonic antigen-producing gastric carcinoma.
    Lan KH; Kanai F; Shiratori Y; Ohashi M; Tanaka T; Okudaira T; Yoshida Y; Hamada H; Omata M
    Cancer Res; 1997 Oct; 57(19):4279-84. PubMed ID: 9331089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tandemly repeated thyroglobulin core promoter has potential to enhance efficacy for tissue-specific gene therapy for thyroid carcinomas.
    Takeda T; Yamazaki M; Minemura K; Imai Y; Inaba H; Suzuki S; Miyamoto T; Ichikawa K; Kakizawa T; Mori J; DeGroot LJ; Hashizume K
    Cancer Gene Ther; 2002 Oct; 9(10):864-74. PubMed ID: 12224028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of protamine to augment adenovirus-mediated cancer gene therapy.
    Lanuti M; Kouri CE; Force S; Chang M; Amin K; Xu K; Blair I; Kaiser L; Albelda S
    Gene Ther; 1999 Sep; 6(9):1600-10. PubMed ID: 10490770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted expression of herpes simplex virus thymidine kinase in adenovirus-infected cells reduces virus titers upon treatment with ganciclovir in vitro.
    Ibrišimović M; Nagl U; Kneidinger D; Rauch M; Lion T; Klein R
    J Gene Med; 2012 Jan; 14(1):3-19. PubMed ID: 22190534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro model for the suicide gene therapy of AFP-producing gastric cancer using HSVtk gene under control of AFP promoter].
    Nakaya H
    Hokkaido Igaku Zasshi; 2003 May; 78(3):203-9. PubMed ID: 12795172
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor cell-specific transgene expression prevents liver toxicity of the adeno-HSVtk/GCV approach.
    Brand K; Löser P; Arnold W; Bartels T; Strauss M
    Gene Ther; 1998 Oct; 5(10):1363-71. PubMed ID: 9930342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoembryonic antigen-specific suicide gene therapy of cytosine deaminase/5-fluorocytosine enhanced by the cre/loxP system in the orthotopic gastric carcinoma model.
    Ueda K; Iwahashi M; Nakamori M; Nakamura M; Matsuura I; Yamaue H; Tanimura H
    Cancer Res; 2001 Aug; 61(16):6158-62. PubMed ID: 11507067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E1A, E1B double-restricted replicative adenovirus at low dose greatly augments tumor-specific suicide gene therapy for gallbladder cancer.
    Fukuda K; Abei M; Ugai H; Kawashima R; Seo E; Wakayama M; Murata T; Endo S; Hamada H; Hyodo I; Yokoyama KK
    Cancer Gene Ther; 2009 Feb; 16(2):126-36. PubMed ID: 18818710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy of experimental malignant mesothelioma using adenovirus vectors encoding the HSVtk gene.
    Esandi MC; van Someren GD; Vincent AJ; van Bekkum DW; Valerio D; Bout A; Noteboom JL
    Gene Ther; 1997 Apr; 4(4):280-7. PubMed ID: 9176512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system.
    Smythe WR; Hwang HC; Amin KM; Eck SL; Davidson BL; Wilson JM; Kaiser LR; Albelda SM
    Cancer Res; 1994 Apr; 54(8):2055-9. PubMed ID: 8174104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.